OTHERS AUTHORIZATION AS SALES AGENT OF XIAMEN AMONMED BIOTECHNOLOGY CO. LTD. FOR COVID-19 DIAGNOSTIC PROCDUCTS

HO WAH GENTING BERHAD

Type Announcement
Subject OTHERS
Description
AUTHORIZATION AS SALES AGENT OF XIAMEN AMONMED BIOTECHNOLOGY CO. LTD. FOR COVID-19 DIAGNOSTIC PROCDUCTS

 

The Board of Directors wishes to announce that Ho Wah Genting Berhad (“HWGB” or the Company”) has received a certificate of authorisation dated 17 March 2020 from Xiamen AmonMed Biotechnology Co. Ltd, with its principal place of business located Unit 503, No. 120, Xinyuan Road, Haicang District, Xiamen, China, for the appointment of HWGB as its designated abroad sales agent for COVID-19 diagnostic products in the region of Malaysia, Singapore, Indonesia and Thailand (“Appointment”).  The validity of the authorisation is from 17 March 2020 to 16 March 2021.

 

Subsequently, the Company had also on the same day submitted an application to the Ministry of Health, Malaysia for the certification of the COVID-19 diagnostic products.

 

Further details will be announced upon the finalisation of the terms and conditions of the Appointment.

 

This announcement is dated 18 March 2020.

 






Announcement Info

Company Name HO WAH GENTING BERHAD
Stock Name HWGB
Date Announced 18 Mar 2020
Category General Announcement for PLC
Reference Number GA1-18032020-00026